Cinnamon is one of those remedies that has been making the rounds in blood sugar conversations for decades. It’s cheap, it’s everywhere, and many studies have been done on it. The findings are genuinely mixed — but not random. The variance in the research comes from some real sources that are worth understanding.

Why cinnamon might work

Cinnamon contains compounds — including cinnamaldehyde and several polyphenols — that appear to have insulin-mimicking properties. They seem to activate certain signaling pathways in cells that normally respond to insulin, improving glucose uptake.

There’s also evidence that some cinnamon compounds inhibit alpha-glucosidase, the same enzyme targeted by an FDA-approved diabetes drug called acarbose. By slowing starch digestion, cinnamon could modestly reduce post-meal glucose spikes.

The mechanism is real and plausible. The question is whether the effect is big enough to matter at the doses people actually consume.

The Ceylon vs. Cassia problem

Here’s something most cinnamon articles leave out: there are two main types of cinnamon sold commercially, and they’re meaningfully different.

Ceylon cinnamon (“true cinnamon,” from Sri Lanka) is expensive, lightly flavored, and contains very little coumarin — a compound that can damage the liver in high doses.

Cassia cinnamon is what fills most spice jars and is used in most supplements. It’s cheaper, stronger-flavored, and contains significant amounts of coumarin. Most positive blood sugar studies used Cassia cinnamon. But Cassia is also the type that raises safety concerns at higher doses.

The European Food Safety Authority has set a tolerable daily intake for coumarin based on liver toxicity data. At the doses used in studies (1–6 grams per day of Cassia cinnamon), some people may exceed safe coumarin levels over time.

What the Khan et al. study found — and why it got complicated

A widely cited 2003 study in Diabetes Care by Khan et al. found that 1–6 grams of cinnamon per day for 40 days reduced fasting blood glucose by 18–29% in people with type 2 diabetes. That’s a large effect. It generated enormous interest.

Subsequent studies have been less impressive. A 2012 Cochrane-style review in the Journal of Diabetes Science and Technology looked at six randomized controlled trials and found no significant effect on A1C. The trials that found effects were often smaller, shorter, and in populations with high baseline blood sugar.

A 2013 meta-analysis in Annals of Family Medicine pooled ten trials and found that cinnamon did modestly reduce fasting blood glucose (by about 10 mg/dL on average) but had no significant effect on A1C — meaning the reduction in fasting glucose didn’t translate to meaningful long-term improvement.

The honest takeaway

Cinnamon at 1–2 grams per day (about half a teaspoon of Cassia, or more of Ceylon) may produce a small reduction in fasting blood glucose. The effect is real in some people and absent in others. It’s not dramatic enough to be a first-line tool, and it doesn’t appear to move A1C significantly.

As a culinary spice on oatmeal, yogurt, or in coffee, there’s no meaningful downside. As a supplement at gram-level doses taken daily, the coumarin concern is worth noting, particularly for people with liver disease or on blood thinners (coumarin is structurally related to warfarin).

If you’re using cinnamon as a supplement rather than a spice, Ceylon is the safer option.


This content is for educational purposes only and is not medical advice. Consult your healthcare provider before making changes to your diet, supplements, or medications.